GSA Capital Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,769
| Closed | -$529K | – | 2041 |
|
|
2022
Q3 | $529K | Buy |
+7,769
| New | +$529K | 0.07% | 530 |
|
|
2022
Q1 | – | Sell |
-49,327
| Closed | -$1.44M | – | 1967 |
|
|
2021
Q4 | $1.44M | Sell |
49,327
-17,075
| -26% | -$500K | 0.18% | 83 |
|
|
2021
Q3 | $1.69M | Buy |
66,402
+59,830
| +910% | +$1.52M | 0.17% | 102 |
|
|
2021
Q2 | $230K | Buy |
+6,572
| New | +$230K | 0.03% | 1116 |
|
|
2019
Q4 | – | Sell |
-5,756
| Closed | -$279K | – | 1828 |
|
|
2019
Q3 | $279K | Buy |
+5,756
| New | +$279K | 0.04% | 960 |
|
|
2019
Q2 | – | Sell |
-4,298
| Closed | -$227K | – | 1824 |
|
|
2019
Q1 | $227K | Buy |
+4,298
| New | +$227K | 0.02% | 1164 |
|
|
2016
Q3 | – | Sell |
-10,900
| Closed | -$181K | – | 2035 |
|
|
2016
Q2 | $181K | Buy |
+10,900
| New | +$181K | 0.01% | 1596 |
|